A Global Effort to Reduce the Costs of a TB Drug Candidate
Simpler and safer methods for making the Phase II TB drug candidate PA-824 have been proposed to the TB Alliance
Simpler and safer methods for making the Phase II TB drug candidate PA-824 have been proposed to the TB Alliance
The Global Alliance for TB Drug Development (TB Alliance) today released the results of a Phase lla study of PA-824,
Eighty years after the discovery of penicillin, researchers say they are on the verge of developing a new class of
The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration
The Global Alliance for TB Drug Development (TB Alliance), a public-private product-development partnership leading the development of new and affordable
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
A collection of photos depicting the reality of extremely drug-resistant tuberculosis (XDR-TB) was unveiled at a kick-off event Friday, October
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
Tuberculosis remains a stubborn foe despite the efforts of the public and private sector’s efforts to deploy new antibiotics and
TOMSK, RUSSIA–Six mornings a week, nurse Galina Kruchinina circles this Siberian city with a black medicine bag. She’s hunting for